Rani Therapeutics

Rani Therapeutics is a biotechnology company that develops pills for the oral delivery of biologic drugs to treat patients with chronic diseases.

Business Model:

Revenue: $2.7M

Employees: 51-200

Detailed Rani Therapeutics Information

Geographic Data

Rani Therapeutics headquarters map

Address: 2051 Ringwood Avenue

City: San Jose

State: CA

Zip: 95131

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$45M

Raised Total:

$257M

Metrics

1,382,283Website Global Rank

20,039Website Monthly Traffic

Twitter Followers

Description

Rani Therapeutics is a biotechnology company that develops pills for the oral delivery of biologic drugs to treat patients with chronic diseases.

Contact Phone:
+14084573700

Contact Email:

Rani Therapeutics went public on 7/30/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
7/30/2021

IPO Valuation:
$528M

Ticker Symbol:
RANI

IPO Price:
$11/share

Amount Raised:
$73M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
7/2013 Series B $0 GV
InCube Ventures
VentureHealth
GV
InCube Ventures
VentureHealth
2/2018 Venture Round $0 AstraZeneca
Shire
Virtus Inspire Ventures
Cathay Venture
Bossa Ventures
Novartis
Ping An Ventures
GeneScience Pharmaceuticals
GV
Bossa Ventures
Cathay Venture
GeneScience Pharmaceuticals
Shire
AstraZeneca
Shire
Virtus Inspire Ventures
Cathay Venture
Bossa Ventures
Novartis
Ping An Ventures
GeneScience Pharmaceuticals
GV
Bossa Ventures
Cathay Venture
GeneScience Pharmaceuticals
Shire
8/2021 IPO $73.3M
8/2017 Series D $39M GV
Astra Zeneca
Bossa Nova Investments
Novartis
5/2015 Series C $0 The Stevanato Group
InCube Ventures
Crystal Horizon Investments
GV
Novartis
Pacific Venture Opportunity Fund
Pinemount Investment
VentureHealth
Western Life Sciences Venture Fund
The Stevanato Group
InCube Ventures
Crystal Horizon Investments
GV
Novartis
Pacific Venture Opportunity Fund
Pinemount Investment
VentureHealth
Western Life Sciences Venture Fund
8/2022 Post-IPO Debt $45M
6/2012 Series A $0 Incube Ventures
Incube Ventures
12/2020 Series E $69M
9/2017 Series D 3 $39M GV
GV
Novartis
AstraZeneca
GV
GV
2/2016 Unattributed -
2/2018 Series D 9 $53M GeneScience Pharmaceuticals
Shire
GV
Novartis
AstraZeneca
Ping An Ventures
Virtus Ventures
Shire
Virtus Inspire Ventures
Cathay Venture
Bossa Ventures
Novartis
Ping An Ventures
AstraZeneca
GeneScience Pharmaceuticals
GV
Bossa Ventures
Cathay Venture
GeneScience Pharmaceuticals
Shire
2/2016 Unattributed - AstraZeneca
Virtus Inspire Ventures
Ping An Ventures
Novartis
Google Ventures
Buttonwood Capital
KPC Pharmaceuticals
InCube Ventures
VentureHealth
AstraZeneca
Virtus Inspire Ventures
Ping An Ventures
Novartis
Google Ventures
Buttonwood Capital
KPC Pharmaceuticals
InCube Ventures
VentureHealth
5/2015 Series C 9 $37.1M
7/2013 Series B 3 $9.4M GV
GV
6/2012 Series A 1 $4M Incube Ventures
Incube Ventures
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research